Rupatadine safety study in people with kidney problems
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial checks how the allergy medicine rupatadine moves through the body and how safe it is for people with different levels of kidney function, compared to people with healthy kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old and Caucasian.
- You must have either normal kidney function or mild, moderate, or severe kidney impairment that has been stable for at least 6 months.
- You cannot be pregnant, breastfeeding, or planning to become pregnant, and women of childbearing age must use effective birth control.
- You must not have a known allergy to rupatadine or similar medicines.
- You must not have taken certain medications or supplements that could interfere with the study in the past few weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study is testing if the allergy medicine rupatadine can help calm inflammation in people with mild to moderate ulcerative colitis. It is for people who are not already on strong UC treatments and want to try a new option.
This trial tests if a new drug, R3R01, can help reduce protein leaking into the urine in people with diabetic kidney disease. It may offer a new option for managing kidney health.
This trial studies whether certain medicines can improve how active rheumatoid arthritis is. If you have rheumatoid arthritis and do not have significant liver or kidney problems, you may be able to join.
Hear when a new Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.